Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milena Bond

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
The Lancet. Rheumatology|January 16, 2025
A glucocorticoid-free era for polymyalgia rheumatica: are we on the brink of change?Milena Bond, Christian Dejaco
Annals of the Rheumatic Diseases|December 10, 2023
Polymyalgia rheumatica: crafting the future of a simple (but not easy!) clinical syndromeMilena Bond, Christian Dejaco
Internal and Emergency Medicine|January 1, 2021
ANCA testing: where are we now?Milena Bond, Filippo Fagni, Augusto Vaglio
Reumatismo|February 13, 2025
To prophylax or not to prophylax? The role of trimethoprim/sulfamethoxazole as a prophylactic agent in systemic vasculitis: the case of antineutrophil cytoplasmic antibody-associated vasculitis and giant cell arteritisAlessandro Tomelleri, Christian Dejaco, Milena Bond
Rheumatology (Oxford, England)|July 29, 2022
Classification criteria for ANCA-associated vasculitis: one size does not fit all!Andreas Kronbichler, Milena Bond, Christian Dejaco
Rheumatology (Oxford, England)|June 17, 2021
IgG4-related disease: not just a matter of IgG4Giorgio Trivioli, Milena Bond, Giacomo Emmi, et al.
Expert Opinion on Investigational Drugs|June 16, 2024
Investigational agents for polymyalgia rheumatica treatment: assessing the critical needs for future developmentLuca Iorio, Roberto Padoan, Milena Bond, et al.
Rheumatology (Oxford, England)|March 12, 2025
Advances in the treatment of polymyalgia rheumaticaLuca Iorio, Milena Bond, Roberto Padoan, et al.
Clinical and Experimental Rheumatology|August 4, 2017
Efficacy of belimumab for the long-term maintenance therapy of thrombocytopenia in systemic lupus erythematosusGinevra De Marchi, Luca Quartuccio, Milena Bond, et al.
Nature Reviews. Rheumatology|June 3, 2024
Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseasesFrank Buttgereit, Andriko Palmowski, Milena Bond, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
The Lancet. Rheumatology|January 16, 2025
A glucocorticoid-free era for polymyalgia rheumatica: are we on the brink of change?Milena Bond, Christian Dejaco
Annals of the Rheumatic Diseases|December 10, 2023
Polymyalgia rheumatica: crafting the future of a simple (but not easy!) clinical syndromeMilena Bond, Christian Dejaco
Internal and Emergency Medicine|January 1, 2021
ANCA testing: where are we now?Milena Bond, Filippo Fagni, Augusto Vaglio
Reumatismo|February 13, 2025
To prophylax or not to prophylax? The role of trimethoprim/sulfamethoxazole as a prophylactic agent in systemic vasculitis: the case of antineutrophil cytoplasmic antibody-associated vasculitis and giant cell arteritisAlessandro Tomelleri, Christian Dejaco, Milena Bond
Rheumatology (Oxford, England)|July 29, 2022
Classification criteria for ANCA-associated vasculitis: one size does not fit all!Andreas Kronbichler, Milena Bond, Christian Dejaco
Rheumatology (Oxford, England)|June 17, 2021
IgG4-related disease: not just a matter of IgG4Giorgio Trivioli, Milena Bond, Giacomo Emmi, et al.
Expert Opinion on Investigational Drugs|June 16, 2024
Investigational agents for polymyalgia rheumatica treatment: assessing the critical needs for future developmentLuca Iorio, Roberto Padoan, Milena Bond, et al.
Rheumatology (Oxford, England)|March 12, 2025
Advances in the treatment of polymyalgia rheumaticaLuca Iorio, Milena Bond, Roberto Padoan, et al.
Clinical and Experimental Rheumatology|August 4, 2017
Efficacy of belimumab for the long-term maintenance therapy of thrombocytopenia in systemic lupus erythematosusGinevra De Marchi, Luca Quartuccio, Milena Bond, et al.
Nature Reviews. Rheumatology|June 3, 2024
Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseasesFrank Buttgereit, Andriko Palmowski, Milena Bond, et al.
Pageof 4